doi: 10.1136/bmj.325.7374.1212.
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study
Affiliations
- PMID: 12446537
- PMCID: PMC135493
- DOI: 10.1136/bmj.325.7374.1212
Item in Clipboard
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study
BMJ.
.
No abstract available
Comment in
-
Cannabis and mental health.BMJ. 2002 Nov 23;325(7374):1183-4. doi: 10.1136/bmj.325.7374.1183. BMJ. 2002. PMID: 12446510 Free PMC article. No abstract available.
Similar articles
-
[A review about cannabis use like as risk factor of schizophrenia].Adicciones. 2007;19(2):191-203. Adicciones. 2007. PMID: 17691420 Review. Spanish.
-
Relationship between cannabis and psychosis: Reasons for use and associated clinical variables.Psychiatry Res. 2015 Sep 30;229(1-2):70-4. doi: 10.1016/j.psychres.2015.07.070. Epub 2015 Jul 28. Psychiatry Res. 2015. PMID: 26235479
-
Cannabis use and psychosocial adjustment in adolescence and young adulthood.Addiction. 2002 Sep;97(9):1123-35. doi: 10.1046/j.1360-0443.2002.00103.x. Addiction. 2002. PMID: 12199828
-
Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective.Aust N Z J Psychiatry. 2000 Jun;34(3):468-75. doi: 10.1080/j.1440-1614.2000.00736.x. Aust N Z J Psychiatry. 2000. PMID: 10881971
-
Interpreting the association between cannabis use and increased risk for schizophrenia.Dialogues Clin Neurosci. 2005;7(1):81-5. doi: 10.31887/DCNS.2005.7.1/mweiser. Dialogues Clin Neurosci. 2005. PMID: 16060598 Free PMC article. Review.
Cited by
-
Cannabidiol versus placebo as adjunctive treatment in early psychosis: study protocol for randomized controlled trial.Trials. 2023 Nov 30;24(1):775. doi: 10.1186/s13063-023-07789-w. Trials. 2023. PMID: 38037108 Free PMC article.
-
A brain imaging study of dopamine receptor D2 availability in cannabis dependent users after recovery from cannabis-induced psychosis.Front Psychiatry. 2023 Oct 27;14:1230760. doi: 10.3389/fpsyt.2023.1230760. eCollection 2023. Front Psychiatry. 2023. PMID: 37965367 Free PMC article.
-
Should oncologists trust cannabinoids?Front Pharmacol. 2023 Jul 13;14:1211506. doi: 10.3389/fphar.2023.1211506. eCollection 2023. Front Pharmacol. 2023. PMID: 37521486 Free PMC article. Review.
-
Medicinal cannabis for psychiatry-related conditions: an overview of current Australian prescribing.Front Pharmacol. 2023 Jun 6;14:1142680. doi: 10.3389/fphar.2023.1142680. eCollection 2023. Front Pharmacol. 2023. PMID: 37346297 Free PMC article.
-
Can we interrogate public databases to fill critical gaps in mental health epidemiology? Testing the association between cannabis and psychosis in the UK as an example.Epidemiol Psychiatr Sci. 2023 Jun 15;32:e40. doi: 10.1017/S2045796023000537. Epidemiol Psychiatr Sci. 2023. PMID: 37317558 Free PMC article.
References
-
- Andréasson S, Allebeck P, Engström A, Rydberg U. Cannabis and schizophrenia: a longitudinal study of Swedish conscripts. Lancet. 1987;ii:1483–1485. - PubMed
-
- Poulton R, Caspi A, Moffitt TE, Cannon M, Murray RM, Harrington H. Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Arch Gen Psychiatry. 2000;57:1053–1058. - PubMed
-
- Silva PA, Stanton WR, editors. From child to adult: the Dunedin multidisciplinary health and development study. Auckland: Oxford University Press; 1996.
-
- Fergusson DM, Horwood LJ. Early onset cannabis use and psychosocial adjustment in young adults. Addiction. 1997;92:279–296. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
